• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型酵母细胞筛选方法鉴定黄酮类化合物为端锚聚合酶抑制剂。

A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor.

机构信息

Chemical Genomics Research Group/Chemical Genetics Laboratory, RIKEN Advanced Science Institute, Wako, Saitama 351-0198, Japan.

出版信息

Biochem Biophys Res Commun. 2010 Apr 9;394(3):569-73. doi: 10.1016/j.bbrc.2010.03.021. Epub 2010 Mar 7.

DOI:10.1016/j.bbrc.2010.03.021
PMID:20214890
Abstract

The telomere-associated protein tankyrase 1 is a poly(ADP-ribose) polymerase and is considered to be a promising target for cancer therapy, especially for BRCA-associated cancers. However, an efficient assay system for inhibitor screening has not been established, mainly due to the difficulty of efficient preparation of the enzyme and its substrate. Here, we report a cell-based assay system for detecting inhibitory activity against tankyrase 1. We found that overexpression of the human tankyrase 1 gene causes a growth defect in the fission yeast Schizosaccharomyces pombe. Chemicals that restore the growth defect phenotype can be identified as potential tankyrase 1 inhibitors. We performed a high-throughput screen using this system, and identified flavone as a compound that restores the growth of yeast cells overexpressing tankyrase 1. Indeed, flavone inhibited poly(ADP-ribosyl)ation of proteins caused by overexpression of tankyrase 1 in yeast cells. This system allows rapid identification of inhibitory activity against tankyrase 1 and is amenable to high-throughput screening using robotics.

摘要

端粒相关蛋白 tankyrase 1 是一种多聚(ADP-核糖)聚合酶,被认为是癌症治疗的一个有前途的靶点,特别是对 BRCA 相关癌症。然而,由于酶及其底物的高效制备存在困难,因此尚未建立有效的抑制剂筛选测定系统。在这里,我们报告了一种用于检测 tankyrase 1 抑制活性的基于细胞的测定系统。我们发现,人 tankyrase 1 基因的过表达会导致裂殖酵母 Schizosaccharomyces pombe 的生长缺陷。能够恢复生长缺陷表型的化学物质可被鉴定为潜在的 tankyrase 1 抑制剂。我们使用该系统进行了高通量筛选,并鉴定出黄酮类化合物是一种能够恢复过表达 tankyrase 1 的酵母细胞生长的化合物。事实上,黄酮类化合物抑制了 tankyrase 1 过表达引起的蛋白质多聚(ADP-核糖)化。该系统可快速鉴定 tankyrase 1 的抑制活性,并且适用于使用机器人进行高通量筛选。

相似文献

1
A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor.一种新型酵母细胞筛选方法鉴定黄酮类化合物为端锚聚合酶抑制剂。
Biochem Biophys Res Commun. 2010 Apr 9;394(3):569-73. doi: 10.1016/j.bbrc.2010.03.021. Epub 2010 Mar 7.
2
Screening and structural analysis of flavones inhibiting tankyrases.筛选和结构分析抑制端锚聚合酶的类黄酮。
J Med Chem. 2013 May 9;56(9):3507-17. doi: 10.1021/jm3018783. Epub 2013 Apr 24.
3
Homogeneous screening assay for human tankyrase.人端锚聚合酶的均相筛选测定法。
J Biomol Screen. 2012 Jun;17(5):593-604. doi: 10.1177/1087057112436558. Epub 2012 Feb 21.
4
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.开发新型双重结合物作为有效、选择性和口服生物利用度的 Tankyrase 抑制剂。
J Med Chem. 2013 Dec 27;56(24):10003-15. doi: 10.1021/jm401317z. Epub 2013 Dec 11.
5
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.发现具有增强效力和同工酶选择性的 tankyrase 抑制黄酮类化合物。
J Med Chem. 2013 Oct 24;56(20):7880-9. doi: 10.1021/jm401463y. Epub 2013 Oct 11.
6
Evaluation of tankyrase inhibition in whole cells.全细胞中端锚聚合酶抑制作用的评估。
Methods Mol Biol. 2007;405:133-46. doi: 10.1007/978-1-60327-070-0_11.
7
3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.3D-QSAR、对接、Flavone 类似物的 ADME/Tox 研究揭示通过 Tankyrase 抑制的抗癌活性。
Sci Rep. 2019 Apr 1;9(1):5414. doi: 10.1038/s41598-019-41984-7.
8
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.一种新型 Tankyrase 小分子抑制剂抑制 APC 突变驱动的结直肠肿瘤生长。
Cancer Res. 2013 May 15;73(10):3132-44. doi: 10.1158/0008-5472.CAN-12-4562. Epub 2013 Mar 28.
9
Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.端粒酶1作为端粒导向分子癌症治疗的靶点。
Cancer Cell. 2005 Jan;7(1):25-37. doi: 10.1016/j.ccr.2004.11.021.
10
Tankyrases as drug targets.端锚聚合酶作为药物靶点。
FEBS J. 2013 Aug;280(15):3576-93. doi: 10.1111/febs.12320. Epub 2013 Jun 18.

引用本文的文献

1
An "In Schizo" Evaluation System to Screen for Human Kinesin-5 Inhibitors.一种用于筛选人驱动蛋白-5 抑制剂的“在精神分裂症中”评估系统。
Methods Mol Biol. 2025;2862:333-351. doi: 10.1007/978-1-0716-4168-2_24.
2
A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.一种新型 HIV-1 抑制剂通过新型酵母和细胞高通量筛选靶向巨噬细胞中 Vpr 诱导的 G2 期阻滞。
Viruses. 2022 Jun 16;14(6):1321. doi: 10.3390/v14061321.
3
3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.
3D-QSAR、对接、Flavone 类似物的 ADME/Tox 研究揭示通过 Tankyrase 抑制的抗癌活性。
Sci Rep. 2019 Apr 1;9(1):5414. doi: 10.1038/s41598-019-41984-7.
4
RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.RK-287107 是一种强效且特异性的 tankyrase 抑制剂,可在临床前模型中阻断结直肠癌细胞生长。
Cancer Sci. 2018 Dec;109(12):4003-4014. doi: 10.1111/cas.13805. Epub 2018 Oct 20.
5
Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.Tankyrase 依赖性聚(ADP-核糖)化和支架调节 Wnt/β-连环蛋白信号传导。
Br J Pharmacol. 2017 Dec;174(24):4611-4636. doi: 10.1111/bph.14038. Epub 2017 Nov 5.
6
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.mTOR信号传导介导Wnt驱动的结直肠癌对端锚聚合酶抑制剂的耐药性。
Oncotarget. 2017 Jul 18;8(29):47902-47915. doi: 10.18632/oncotarget.18146.
7
Panspecies small-molecule disruptors of heterochromatin-mediated transcriptional gene silencing.异染色质介导的转录基因沉默的全物种小分子干扰剂。
Mol Cell Biol. 2015 Feb;35(4):662-74. doi: 10.1128/MCB.01102-14. Epub 2014 Dec 8.
8
Anti-cancer drug discovery: update and comparisons in yeast, Drosophila, and zebrafish.抗癌药物发现:酵母、果蝇和斑马鱼模型的进展与比较
Curr Mol Pharmacol. 2014;7(1):44-51. doi: 10.2174/1874467207666140702113629.
9
Structural Implications for Selective Targeting of PARPs.聚(ADP - 核糖)聚合酶(PARP)选择性靶向的结构影响
Front Oncol. 2013 Dec 20;3:301. doi: 10.3389/fonc.2013.00301.
10
Identification through high-throughput screening of 4'-methoxyflavone and 3',4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos.通过高通量筛选鉴定4'-甲氧基黄酮和3',4'-二甲氧基黄酮作为新型PARP-1依赖性细胞坏死神经保护抑制剂。
Br J Pharmacol. 2013 Jul;169(6):1263-78. doi: 10.1111/bph.12201.